GEHC
$69.65-0.73 (-1.04%)
GE HealthCare Technologies Inc.
Recent News
GEHC Acquires Intelerad to Boost Cloud-First, AI Imaging Capabilities
GE HealthCare completes the $2.3B Intelerad deal to expand AI-driven imaging, boost recurring revenues and strengthen its cloud-first healthcare platform.
Stryker Investors Weigh Cyberattack Recovery As CEO Joins GE HealthCare Board
Stryker CEO Kevin Lobo has been appointed to the Board of Directors of GE HealthCare. The appointment links leadership at two large medical technology companies with global reach. Stryker, traded as NYSE:SYK, enters this leadership development with its shares at $345.81. Over the past 3 years the stock shows a total return of 30.7%, and over 5 years a total return of 55.7%, which gives investors some historical context for how the company has rewarded long term holders. For investors...
GEHC & Springbok Collaborate on MRI Muscle Analysis for Sports
GE HealthCare teams with Springbok to pair MRI tech with AI muscle analytics, aiming to redefine how muscle health is measured and visualized.
Hologic's Women's Health Index Flags Alarming Gaps in STI Screening
HOLX's Global Women's Health Index shows STI testing stagnates at 10%, leaving nearly 2 billion women at risk despite gains in other screenings.
Should You Hold or Sell HOLX Stock as It Nears the End of Public Phase?
Hologic nears its $76 buyout price as Diagnostics faces headwinds, tariffs hurt, and the stock trades at a sector premium.